Abstract
This market insight report gives an insight into Apoptosis Molecular Pathways - Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators and p53 Modulators. The study also focuses on major diseases for which the treatment is based on apoptosis comprising Cancer, Neurodegenerative Diseases, Cardiovascular Diseases and other apoptosis based diseases including HIV Infection, Organ Transplant Rejection and MODS. The study provides global market analysis for apoptosis related therapeutic products by the above apoptosis molecular pathways and also by the disease areas. Estimates and projections for the total global apoptosis related therapeutic products market are given by geographic regions encompassing United States, Europe, Japan and Rest of World.
Business profiles of 41 major companies are discussed in the report. The report covers 256 companies that are engaged in apoptosis research, testing and supply of products and services. Major Contract Research Organizations and Universities serving apoptosis market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 61 exhibits complement the text.
Table of Contents
I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
1. Foreword
- Apoptosis
- Segmentation of Apoptosis
- Exhibit 1: Segmentation of Global Apoptosis Related Products Market by apoptosis molecular pathways (Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other) and Therapeutic Areas (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases and Other)
- Segmentation of Apoptosis
2. Global Market Analysis
- Exhibit 2: Apoptosis Related Products (2005-2012) - Global Market Analysis
(Current & Future) in US$ Million (Graphical Representation Included)
- Analysis of Apoptosis Related Products by Molecular Pathways
- Caspases
- Exhibit 3: Caspase Activators and Inhibitors (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 4: Caspase Activators and Inhibitors (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
- Protease Inhibitors
- Exhibit 5: Protease Inhibitors (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 6: Protease Inhibitors (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
- Bcl-2 Modulators
- The Role of Bcl-2 in Diseases
- Exhibit 7: Bcl-2 Modulators (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 8: Bcl-2 Modulators (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
- p53 Modulators
- Exhibit 9: p53 Modulators (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 10: p53 Modulators (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
- Other
- Exhibit 11: Other Molecular Pathways of Apoptosis (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 12: Other Molecular Pathways of Apoptosis (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
- Caspases
- Analysis of Apoptosis Related Products by Therapeutic Area
- Cancer
- Role of Apoptosis Proteins and Genes in Cancer
- Bcl-2 Modulators
- IAPs
- Exhibit 13: Apoptosis Related Therapeutic Products for Cancer (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 14: Apoptosis Related Therapeutic Products for Cancer (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
- Role of Apoptosis Proteins and Genes in Cancer
- Neurodegenerative Diseases
- Exhibit 15: Apoptosis Related Therapeutic Products for Neurodegenerative Diseases (2005- 2011) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 16: Apoptosis Related Therapeutic Products for Neurodegenerative Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
- Cardiovascular Diseases
- Exhibit 17: Apoptosis Related Therapeutic Products for Cardiovascular Diseases (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 18: Apoptosis Related Therapeutic Products for Cardiovascular Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
- Other
- Exhibit 19: Therapeutic Products for Other Apoptosis Based Diseases (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 20: Therapeutic Products for Other Apoptosis Based Diseases (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World
- Exhibit 21: List of Major Global Companies
- Cancer
- Analysis of Apoptosis Related Products by Molecular Pathways
3. Regional Market Analysis
- The United States
- Exhibit 22: Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
- A Glance at Major Companies in the United States
- A.G. Scientific
- Abbott Laboratories
- Alexion Pharmaceuticals
- Alfacell Corporation
- Amgen
- Applied Molecular Evolution
- Ariad Pharmaceuticals
- ArQule
- AVI BioPharma
- BD Biosciences
- Cyclacel Pharmaceuticals
- Dendreon Corporation
- EntreMed
- EpiCept Corporation
- Genta, Inc
- Genzyme Corporation
- Human Genome Sciences
- Incyte Corporation
- Introgen Therapeutics, Inc
- ISIS Pharmaceuticals
- Keryx Biopharmaceuticals
- MGI Pharma
- Millennium Pharmaceuticals
- North American Scientific
- Onyx Pharmaceuticals
- OSI Pharmaceuticals
- Pfizer
- Pharmacyclics
- Schering-Plough
- Senesco Technologies
- Sigma-Aldrich Corporation
- Telik, Inc
- Vertex Pharmaceuticals
- Titan Pharmaceuticals
- Europe
- Exhibit 23: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
- A Glance at Major Companies in Europe
- Antisoma plc (UK)
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Miltenyi Biotec GmbH
- Novartis AG (Switzerland)
- Zentaris GmbH (Germany)
- Japan
- Exhibit 24: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
- Takeda Pharmaceutical Co., Ltd. - A Major Market Player
- Rest of World
- Exhibit 25: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation Included)
- A Glance at Major Companies in Rest of World Region
- Aegera Therapeutics, Inc. (Canada)
- Aida Pharmaceuticals, Inc. (China)
- D-Pharm Ltd. (Israel)
- Novogen Limited (Australia)
- Vasogen, Inc. (Canada)
III. PRODUCT RESEARCH
1. Introduction
- Apoptosis - The Major Form of Programmed Cell Death
- Global Growth Trends - Apoptosis Related Therapeutic Products
- Exhibit 26: Global Market for Apoptosis Related Therapeutic Products: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- The Process of Apoptosis
- Cell Death Due to Injury
- Cell Death Due to Suicide
- Reasons for Cell Suicide
- Procedures for Apoptosis Identification
- The ISEL technique
- TUNEL technique
- Methods for Understanding Apoptosis
- DNA Fragmentation to Aid Apoptosis Measurement
- Measurement of Variations in Apoptosis by Cdk2
- Apoptotic Cell Clearance Measurement In Vitro
- Exploring Apoptosis in Drosophila' s
- Global Growth Trends - Apoptosis Related Therapeutic Products
2. Apoptosis Molecular Pathways
- Growth Trends - Global Apoptosis Related Therapeutic Products by Molecular
Pathways
- Exhibit 27: Global Market for Apoptosis Related Therapeutic Products: Apoptosis Molecular Therapeutics (Bcl-2 Modulators, p53 Modulators, Caspases and Protease Inhibitors) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Key Molecular Pathways of Apoptosis
- Caspases
- Growth Trends - Global Market for Caspase Activators and Inhibitors
- Exhibit 28: Global Market for Caspase Activators and Inhibitors: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Types of Caspase Proteins
- Initiator Caspases
- Effector Caspases
- The Caspase Flow
- Function of Caspases in Apoptosis, Development and Cytokine Maturation
- Card Domains
- Protease Inhibitors
- Growth Trends - Global Market for Protease Inhibitors
- Exhibit 29: Global Market for Protease Inhibitors: Geographic Regions (Japan, Europe and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Growth Trends - Global Market for Protease Inhibitors
- Bcl-2 Modulators
- Growth Trends - Global Market for Bcl-2 Modulators
- Exhibit 30: Global Market for Bcl-2 Modulators: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Structure of Bcl-2 Family
- The Role of Bcl-2 in Diseases
- Biochemical Properties of Bcl-2 Proteins
- Cytoplasmic Proteins
- Growth Trends - Global Market for Bcl-2 Modulators
- p53 Modulators
- Growth Trends - Global Market for p53 Modulators
- Exhibit 31: Global Market for p53 Modulators: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Growth Trends - Global Market for p53 Modulators
- Other Apoptosis Molecular Pathways
- Inhibitors of Apoptosis Proteins
- Identification of IAP Gene Family Proteins
- TRAIL
- MLK Inhibitor
- Factor 5A
- Protein Kinase Pathway Modulators
- Chemotherapeutic Role of Telcyta in Various Cancers
- Nicotinic Acetylcholine Receptor Agonist
- HSP27
- Inhibitors of Apoptosis Proteins
3. Disease Areas Connected with Apoptosis
- Growth Trends - Global Market for Apoptosis Therapeutic Areas
- Exhibit 32: Global Market for Apoptosis Therapeutic Products: Major Apoptosis Related Therapeutic Areas (Neurodegenerative Diseases, Cardiovascular Diseases and Cancer) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Cancer
- Major Companies in Global Cancer Market
- Exhibit 33: Global Market for Cancer Therapeutic Products (2005 & 2006): Percentage Breakdown of Market Share for Top 10 Companies - Roche, Sanfo-Aventis, Amgen, Astra-Zeneca, Novartis, Johnson & Johnson, Bristol-Myer Squibb, Schering-Plough, Pfizer, Eily-Lilly (Graphical Representation Included)
- Growth Trends - Global Market for Apoptosis Related Therapeutic
Products for Cancer
- Exhibit 34: Global Market for Apoptosis Related Therapeutic Products for Cancer: Geographic Regions (Japan, United States and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Major Companies in Global Cancer Market
- Neurodegenerative Disease
- Growth Trends - Global Market for Apoptosis Related Therapeutic
Products for Neurodegenerative Disease
- Exhibit 35: Global Market for Apoptosis Related Therapeutic Products for Neurodegenerative Disease: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Alzheimer' s
- Importance of Apoptosis in Alzheimer' s Disease
- Familial Alzheimer' s Disease and Role Of Mutant APP
- Parkinson' s
- Function of Apoptosis in PD and Symptoms of Neuronal Degradation
- Apoptosis in Parkinson' s Disease and Nigral Neuronal Death
- Potential Markers of Apoptosis in Parkinson' s Disease
- Rheumatoid Arthritis
- Role of Apoptosis in Rheumatoid Arthritis Synovium
- Multiple Sclerosis
- The Diagnosis of MS
- Functioning of Oligodendrocytes Apoptosis in MS and EAE
- Growth Trends - Global Market for Apoptosis Related Therapeutic
Products for Neurodegenerative Disease
- Cardiovascular Diseases - Role of Cell Apoptosis
- Growth Trends - Global Market for Apoptosis Related Therapeutic
Products for Cardiovascular Disease
- Exhibit 36: Global Market for Apoptosis Related Therapeutic Products for Cardiovascular Disease: Geographic Regions (United States, Japan and Europe) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation Included)
- Growth Trends - Global Market for Apoptosis Related Therapeutic
Products for Cardiovascular Disease
- Other Apoptosis Based Diseases
- Organ Transplant Rejection
- Types of Organ Rejection
- Hyperacute Rejection
- Acute Rejection
- Chronic Rejection
- Treating Rejection
- HIV Infection
- Sepsis and Multiple Organ Dysfunction Syndrome
- Requirement of Logical Strategies
- Sepsis Controlled by Apoptosis
4. Apoptosis Therapeutics
- Technologies Involved in Drug Making Process for Apoptosis Based Treatment
- Target Discovery and Validation
- Structural Biology
- Drug Candidate Identification
- Antisense
- Types of Antisense
- The nbl Antisense
- Antisense CK2
- Np73 Antisense
- Np73 Function in SH-SY5Y Neuroblastoma Cells
- Types of Antisense
- Small Molecule Mimetics
- Antisense
- Drug Discovery
- Combinatorial Chemistry
- High Throughput Screening
- Target Discovery and Validation
- Analysis of Apoptosis Based Drugs - Listed by Molecular Pathways
- Caspases
- Executioner Caspases
- CASPASE-8
- Caspase-3
- IDN-6556
- Application of IDN-6556 for Human Liver Preservation Injury
- MX1122
- MX1013
- Executioner Caspases
- Protease Inhibitors
- VELCADE™ (BORTEZOMIB)
- Bcl-2 Modulators
- Genase
- Genasense in combination with chemotherapy
- Genasense: Positive effects On Bladder Tumor
- HA14-1
- Genase
- p53 Modulators
- SCH58500
- INGN 241
- INGN 241 in combination with Introgen
- Administration of INGN 241 with Herceptin
- INGN 251
- ONYX-015
- Apoptosis Related Products in Developments
- The Combination of Apoptosis with Anti-Angiogenesis Yields Better Results
- Personalized Cancer Therapy with Caspase-3
- Exhibit 37: Some of the Apoptosis Related Products in Development
- Caspases
IV. MARKET DYNAMICS
1. Market Overview
- Global Market Analysis
- Exhibit 38: Apoptosis Related Products (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan and Rest of World in US$ Million (Graphical Representation Included)
- Exhibit 39: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan and Rest of World (Graphical Representation Included)
2. Major Companies in Apoptosis Market
- A.G. Scientific, Inc. (USA)
- Abbott Laboratories (USA)
- Aegera Therapeutics, Inc. (Canada)
- Aida Pharmaceuticals, Inc. (China)
- Alexion Pharmaceuticals, Inc. (USA)
- Alfacell Corporation (USA)
- Amgen, Inc. (USA)
- Antisoma plc (UK)
- Applied Molecular Evolution (USA)
- Ariad Pharmaceuticals, Inc. (USA)
- ArQule, Inc (USA)
- AVI BioPharma Inc. (USA)
- BD Biosciences (USA)
- Cyclacel Pharmaceuticals, Inc. (USA)
- Dendreon Corporation (USA)
- D-Pharm Ltd. (Israel)
- EntreMed, Inc. (USA)
- EpiCept Corporation (USA)
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Genta, Inc. (USA)
- Genzyme Corporation (USA)
- Incyte Corporation (USA)
- Introgen Therapeutics, Inc. (USA)
- Invitrogen, Inc. (USA)
- ISIS Pharmaceuticals, Inc. (USA)
- MGI Pharma, Inc. (USA)
- Millennium Pharmaceuticals Inc. (USA)
- Miltenyi Biotec GmbH
- Novartis AG (Switzerland)
- Novogen Limited (Australia)
- Onyx Pharmaceuticals, Inc. (USA)
- OSI Pharmaceuticals, Inc. (USA)
- Pfizer, Inc. (USA)
- Pharmacyclics, Inc. (USA)
- Schering-Plough Corporation (USA)
- Sigma-Aldrich Corporation (USA)
- Takeda Pharmaceutical Co., Ltd. (Japan)
- Titan Pharmaceuticals, Inc. (USA)
- Vasogen, Inc. (Canada)
- Vertex Pharmaceuticals, Inc. (USA)
- Zentaris GmbH (Germany)
3. Recent Activities in Apoptosis Market
- EntreMed Announces Results for ENMD-1198 and Vincristine in Pre-clinical Leukemia Models
- Arius Signs Agreement with Avid Bioservices for CD44 Cancer Stem Cell Antibody
- EntreMed Starts Phase II Study with MKC-1 to Treat Pancreatic Cancer
- AnaSpec Launches Bcl Peptides
- BioLineRx Acquires the Anti-Cancer Compound BL-4060
- Phase II Multi-Center Clinical Trial Enrollment for NSCLC Completed
- Cell Signaling Technology Offers PhosphoScan® Profiling Technology and PhosphoSite® Knowledgebase to Academic Researchers
- Cambridge Antibody Technology Merges into MedImmune
- Human Genome Sciences Shows Anti-Tumor Activity and Efficacy of TRAIL Receptor Antibodies When Combined with Chemotherapy
- ImClone and Bristol-Myers Squibb Form an Agreement with Merck KGaA to Jointly Develop and Commercialize ERBITUX® in Japan
- Cyclacel Pharmaceuticals Buys Specialty Pharmaceutical Business Focused on the Oncology Market
- EpiCept Successfully Completes Phase I Trial for EPC2407 in Apoptosis Induction
- Aegera Therapeutics Acquires LymphoSign Inc and Closes Concurrent Financing
- Genentech Purchases Stake in Tanox
- Cell Signaling Technology, Inc. Increases its PhosphoScan® Patent Portfolio
- TopoTarget Acquires Apoxis SA
- Myriad Genetics and AstraZeneca Collaborate on New Treatment for BRCA1 & BRCA2 Mutations
- Azixa™ of Myriad Genetics in Phase II for Brain Cancer
- Takeda Pharmaceuticals and CanBas in Collaboration for Cancer Treatment
- BD Biosciences Collaborates with Roche to Accelerate the Study of Cell Signal Transduction Using New Phosphorylation Site Antibody Targets and Applications
- MMRC Joins Hands with Keryx
- EpiCept' s EPC2407 Well Suited for Lymphomas and Advanced Stage in Cancer
- Gemin X Undertakes Further Research on GX15-070
- XOMA Ties-up with Takeda
- TorreyPines Therapeutics Merges with Axonyx
- Aida Acquires Qiaer Bio-Technology
- Enzon and Santaris in Collaboration for a Series of RNA Antagonists
- Millipore Acquires Serologicals Corp.
- Stressgen Assumes New Corporate Identity
- Sigma-Aldrich Launches PanoramaTM
- CST Signs Pact with AstraZeneca
- Takeda Enters into Partnership with Arius
- EpiCept Joins Hands with Maxim
- Targacept Signs Partnership and Licensing Agreement with AstraZeneca
- Apoxis Enters into Deal with Astellas Pharma
- PIramed Enters into Alliances with Genentech
- Invitrogen Takes Over BioSource International
- MedImmune Signs Agreement with VasGene
- Nanocure Adopts New Corporate Identity
- Pfizer Inc., Acquires Idun Pharmaceuticals
- AXXORA Merges with APOTECH
- Invitrogen Takes Over Zymed Laboratories
- B-Bridge Enters into Deal with RZPD
4. Regional Market Analysis
- A. The United States
- Analysis by Apoptosis Molecular Pathways
- Exhibit 40 Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
- Exhibit 41: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
- Analysis by Therapeutic Area
- Exhibit 42: Apoptosis Related Products (2005-2012) - United States Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
- Exhibit 43: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
- Exhibit 44: List of Major Companies in the United States
- Analysis by Apoptosis Molecular Pathways
- B. Europe
- Analysis by Geographic Region
- Exhibit 45: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, France and Rest of Western Europe in US$ Million (Graphical Representation Included)
- Exhibit 46: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, France and Rest of Western Europe
- Analysis by Apoptosis Molecular Pathways
- Exhibit 47: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
- Exhibit 48: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
- Analysis by Therapeutic Area
- Exhibit 49: Apoptosis Related Products (2005-2012) - European Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
- Exhibit 50: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
- Exhibit 51: List of Major Companies in the Europe
- Analysis by Geographic Region
- C. Japan
- Analysis by Apoptosis Molecular Pathways
- Exhibit 52: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
- Exhibit 53: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
- Analysis by Therapeutic Area
- Exhibit 54: Apoptosis Related Products (2005-2012) - Japanese Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
- Exhibit 55: Apoptosis Related Products (2006, 2009 and 2012)- Percentage Breakdown of Japanese Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other (Graphical Representation Included)
- Exhibit 56: List of Major Companies in Japan
- Analysis by Apoptosis Molecular Pathways
- D. Rest of World
- Analysis by Apoptosis Molecular Pathways
- Exhibit 57: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other in US$ Million (Graphical Representation Included)
- Exhibit 58: Apoptosis Therapeutic Products (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Apoptosis Molecular Pathways for Caspases, Protease Inhibitors, Bcl-2 Modulators, p53 Modulators and Other
- Analysis by Therapeutic Area
- Exhibit 59: Apoptosis Related Products (2005-2012) - Rest of World Market Analysis (Current & Future) by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other in US$ Million (Graphical Representation Included)
- Exhibit 60: Apoptosis Related Products (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Therapeutic Area for Cancer, Neurodegenerative, Cardiovascular and Other
- Exhibit 61: List of Major Companies in Rest of World
- Analysis by Apoptosis Molecular Pathways
